Akèy › Kansè nan tete › Tennessee › Chattanooga
Etid klinik pou Kansè nan tete nan Chattanooga, TN
3 etid pou Kansè nan tete ap chèche patisipan nan sit nan ak bò kote Chattanooga (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Ap rekriteFaz 3
- Research Site, Chattanooga
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast Cancer
Ap rekriteFaz 1/2
- Tennessee Oncology - Chattanooga Oncology & Hematology Associates, Chattanooga
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
Ap rekriteFaz 2
- Sarah Cannon Research Institute, Chattanooga
Etid Kansè nan tete nan lòt vil
- New York City, NY136 etid
- Houston, TX126 etid
- Boston, MA112 etid
- Nashville, TN81 etid
- Los Angeles, CA73 etid
- Edison, NJ68 etid
- St. Louis, MO64 etid
- Queens, NY64 etid
- Durham, NC64 etid
- Chicago, IL59 etid
- Philadelphia, PA56 etid
- Dallas, TX55 etid
Lòt etid nan Chattanooga
- Kansè Poumon ki pa ti selil11 etid
- Kansè Metastatik6 etid
- Miasteni grav6 etid
- Kansè ovè5 etid
- Dyabèt4 etid
- Maladi fwa steatotik4 etid
- Melanom4 etid
- Akidan serebral iskemi4 etid
- Kansè kolorektal4 etid
- Maladi ren kwonik4 etid
- Kansè poumon4 etid
- Ensifizans renn3 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.